Successful, we will reply to you quickly.


Please select the quantity.


Your message is being sent, please wait.




Send mail failed, please send again!


Products are for research use only. Not for human use. We do not sell to patients.

Signaling Pathway



(CDP-323; CDP 323; CDP323)


Zaurategrast Chemical Structure

Zaurategrast(CDP-323) is an oral α4-integrin inhibitor.

Size Price Stock Quantity
Free sample   Apply now  
10 mM * 1 mL in DMSO $195 In-stock
5 mg $170 In-stock
10 mg $300 In-stock
25 mg $590 In-stock
50 mg Get quote
100 mg Get quote
Size Price Stock Quantity
Free sample   Apply now  
10 mM * 1 mL in DMSO €191 In-stock
5 mg €167 In-stock
10 mg €294 In-stock
25 mg €578 In-stock
50 mg Get quote
100 mg Get quote

* Please select Quantity before adding items.

Bulk Inquiry

Inquiry Information
Product name: Zaurategrast
Cat. No.: HY-70073

Zaurategrast Data Sheet

  • View current batch:

    Purity: 99.53%

  • Network Version


    Pdf Version Network Version


    Pdf Version


Related Compound Libraries

Biological Activity of Zaurategrast

Zaurategrast(CDP-323) is an oral α4-integrin inhibitor.
IC50 value:
Target: α4-integrin
CDP323 significantly decreased the capacity of lymphocytes to bind vascular adhesion molecule-1 (VCAM-1) and the expression of α4-integrin on VCAM-1-binding cells.CDP323 at daily doses of 1000 or 2000 mg induced significant increases in total lymphocyte count and suppressed VCAM-1 binding by reducing unbound very late antigen-4 expression on lymphocytes.

Protocol (Extracted from published papers and Only for reference)


Chemical Information

M.Wt 521.41 Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Formula C₂₆H₂₅BrN₄O₃
CAS No 455264-31-0
Solvent & Solubility

10 mM in DMSO

Preparing Stock Solutions

1 mg 5 mg 10 mg
1 mM 1.9179 mL 9.5894 mL 19.1788 mL
5 mM 0.3836 mL 1.9179 mL 3.8358 mL
10 mM 0.1918 mL 0.9589 mL 1.9179 mL

References on Zaurategrast

Inhibitor Kit

Related Integrin Products

  • Arg-Gly-Asp-Ser

    Arg-Gly-Asp-Ser(RGDS peptide) is an integrin binding sequence that inhibits integrin receptor function; decreases systemic inflammation via inhibition of collagen-triggered activation of leukocytes and attenuates expression of inflammatory cytokines, iNOS and MMP-9.

  • CWHM-12

    CWHM-12 a novel small molecule inhibitor of (alpha)V integrins with IC50s of 1.8/0.8/1.5/0.2 nM for (alpha)v(beta)1/(alpha)v(beta)3/(alpha)v(beta)8; less potency on (alpha)v(beta)5(IC50=61 nM) and on inhibition on (alpha)IIb(beta)3/(alpha)2(beta)1/(alpha)10(beta)1.

  • Cyclo(-RGDfK)

    Cyclo(-RGDfK) is a potent and selective inhibitor of the (alpha)v(beta)3 integrin.

  • Cyclo(RADfK)

    Cyclo(RADfK) is a selective (alpha)(v)(beta)(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis.

  • E7820

    E7820 is an angiogenesis inhibitorby suppressing integrin a2, a cell adhesion molecule expressed on endothelial cells.

  • Firategrast

    Firategrast is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS).

  • ILK-IN-1

    ILK-IN-1 is a novel ILK inhibitor with IC50 of 0.6 (mu)M.

  • ILK-IN-2

    ILK-IN-2 is a ILK inhibitor.

  • Integrin Antagonists 27

    Integrin Antagonists 27 is a small molecule integrin (alpha)v(beta)3 antagonist with binding affinity of 18 nM, as s novel anticancer agent.

  • TR-14035

    TR-14035 is a a dual alpha4beta7(IC50=7 nM)/alpha4beta1 (IC50=87 nM) integrin antagonist .